Paris, France

Leticia Niborski

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):

Title: Leticia Niborski: Innovator in Engineered Immune Cells

Introduction

Leticia Niborski is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly in the development of engineered immune cells. With a total of 3 patents, her work focuses on advancing cancer treatment through innovative cellular therapies.

Latest Patents

One of her latest patents involves the creation of immune cells defective for SUV39H1. This invention relates to an engineered immune cell that is specifically designed to inhibit the expression and/or activity of Suv39h1. The engineered immune cell also includes a genetically engineered antigen receptor that binds to a target antigen. This invention is particularly relevant for adoptive therapy, offering new avenues for cancer treatment.

Career Highlights

Leticia has worked with esteemed institutions such as Institut Curie and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in the field of cancer immunotherapy, showcasing her dedication to improving patient outcomes through innovative solutions.

Collaborations

Leticia has collaborated with notable colleagues in her field, including Sebastian Amigorena and Eliane Piaggio. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Leticia Niborski stands out as a leading innovator in the realm of engineered immune cells. Her patents and collaborations reflect her commitment to advancing cancer treatment through groundbreaking research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…